Serotonin syndrome;Le syndrome sérotoninergique

Revue Medicale de Bruxelles

Volumn 23, Issue 5, 2002, Pages 422-428

  Lheureux, P ^a   Penaloza, A ^a   De Cottenier, V ^a   Ullmann, U ^a   Gris, M ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Adverse drug effects; Chlorpromazine; Cyproheptadine; Drug interactions; Serotonin syndrome

Indexed keywords

CHLORPROMAZINE; CYPROHEPTADINE; PSYCHOTROPIC AGENT; SEROTONIN; SEROTONIN 2 ANTAGONIST;

ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; HUMAN; NEUROLEPTIC MALIGNANT SYNDROME; NEUROMUSCULAR DISEASE; SEROTONIN SYNDROME; SEROTONINERGIC SYSTEM; SYMPTOMATOLOGY;

DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; HUMANS; IATROGENIC DISEASE; INCIDENCE; RECEPTORS, SEROTONIN; RISK FACTORS; SEROTONIN AGENTS; SEROTONIN SYNDROME;

EID: 0036801817     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mitchell RS: Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis. Ann Intern Med 1955; 42: 417-24
2. Insel TR, Roy BF, Cohen RM, Murphy DL: Possible development of the serotonin syndrome in man. Am J Psychiatry 1982; 139: 954-5
3. Sternbach H: The Serotonin Syndrome. Am J Psychiat 1991; 148: 705-13
4. Mills KC: Serotonin syndrome. Am Fam Physician 1995; 52: 1475-82
5. Sporer KA: The serotonin syndrome. Implicated drugs, pathophysiology and management. Drug Saf 1995; 13: 94-104
6. Martin TG: Serotonin Syndrome. Ann Emerg Med 1996; 28: 520-6
7. Ruiz F: Fluoxetine and the serotonin syndrome. Ann Emerg Med 1994; 24: 983-5
8. Fugh-Berman A: Herb-drug interactions. Lancet 2000; 355: 134-8
9. Skop BP, Finkelstein JA, Mareth TR, Magoon MR, Brown TM: The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1994; 12: 642-4
10. Mills KC: Serotonin syndrome. A clinical update. Crit Care Clin 1997; 13: 763-83
11. Carbone JR: The neuroleptic malignant and serotonin syndromes. Emerg Med Clin North Am 2000; 18: 317-25
12. John L, Perreault MM, Tao T, Blew PG: Serotonin syndrome associated with nefazodone and paroxetine. Ann Emerg Med 1997; 29: 287-9
13. Graber MA, Hoehns TB, Perry PJ: Sertraline-phenelzine drug interaction: A serotonin syndrome reaction. Ann Pharmacother 1994; 28: 732-5
14. Guze BH, Baxter LR Jr: The serotonin syndrome: Case responsive to propranolol. J Clin Psychopharmacol 1986; 6: 119-20
15. Lappin RI, Auchincloss EL: Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994; 331: 1021-2
16. Horowitz BZ, Mullins ME: Cyproheptadine for serotonin syndrome in an accidental pediatric sertraline ingestion. Pediatr Emerg Care 1999; 15: 325-7
17. McDaniel WW: Serotonin syndrome: Early management with cyproheptadine. Ann Pharmacother 2001; 35: 870-3
18. Graudins A, Stearman A, Chan B: Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16: 615-9
19. Gillman PK: Serotonin syndrome treated with chlorpromazine. J Clin Psychopharmacol 1997; 17: 128-9
20. Graham PM: Successful treatment of the toxic serotonin syndrome with chlorpromazine. Med J Aust 1997; 166: 166-7
21. Gillman PK: Successful treatment of serotonin syndrome with chlorpromazine. Med J Aust 1996; 165: 345-6